INS and obesity disorder: Plasma acylcarnitine profiles were characterized in patients with obesity and T2D during fasting and insulin-stimulated conditions in Mihalik’s study27 to find out the site of derangements in FAO and electron transport chain (ETC) activity in obesity and T2D.